TCM

Tekla Capital Management Portfolio holdings

AUM $2.56B
1-Year Est. Return 18.15%
This Quarter Est. Return
1 Year Est. Return
+18.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.59B
AUM Growth
-$205M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
169
New
Increased
Reduced
Closed

Top Buys

1
+$42.1M
2
+$23.4M
3
+$21.4M
4
CELG
Celgene Corp
CELG
+$13.2M
5
SAGE
Sage Therapeutics
SAGE
+$11.2M

Top Sells

1
+$25.8M
2
+$23.6M
3
+$21.4M
4
GILD icon
Gilead Sciences
GILD
+$20.1M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$18.4M

Sector Composition

1 Healthcare 92.75%
2 Real Estate 2.87%
3 Financials 0.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
101
$3.3M 0.13%
+25,000
102
$3.29M 0.13%
450,000
-50,000
103
$3.28M 0.13%
275,000
104
$3.25M 0.13%
37,300
105
$3.1M 0.12%
215,800
-215,800
106
$3.03M 0.12%
356,237
-39,581
107
$2.93M 0.11%
46,466
-28,534
108
$2.93M 0.11%
5,000
109
$2.85M 0.11%
+350,300
110
$2.75M 0.11%
+278,700
111
$2.74M 0.11%
740,769
+286,869
112
$2.65M 0.1%
+88,918
113
$2.6M 0.1%
74,397
+44,389
114
$2.56M 0.1%
+26,170
115
$2.54M 0.1%
+8,400
116
$2.49M 0.1%
164,500
117
$2.4M 0.09%
16,220
-27,741
118
$2.38M 0.09%
162,900
119
$2.21M 0.09%
449,255
+126,000
120
$2.2M 0.08%
171,813
+130,894
121
$2.19M 0.08%
40,035
-40,035
122
$2.18M 0.08%
68,000
123
$2.07M 0.08%
124,335
124
$1.99M 0.08%
38,706
+14,406
125
$1.95M 0.08%
14,324
3 4
5
6 7